PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −15 vs. Q4 2024
- Shares held
- 37.3M
- −1.64M (−4.2%) vs. Q4 2024
- Total value
- $40.7M
- −$18.2M (−30.9%) vs. Q4 2024
- New holders
- 1
- 9 more added
- Sold out
- 16
- 32 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 384 | $0 | 0.00% | −40,000−99.0% | Reduced |
| FMR LLC | 315 | $343 | 0.00% | −690−68.7% | Reduced |
| BNP Paribas Arbitrage, SA | 544 | $593 | 0.00% | −219−28.7% | Reduced |
| Tower Research Capital LLC (TRC) | 720 | $785 | 0.00% | −805−52.8% | Reduced |
| Jones Financial Companies LLLP | 1,000 | $1.11K | 0.00% | 00.0% | Unchanged |
| Public Employees Retirement System of Ohio | 2,092 | $2.28K | 0.00% | −2,846−57.6% | Reduced |
| CI Private Wealth, LLC | 10,000 | $10.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,000 | $10.9K | 0.00% | +10,000 | New |
| Group One Trading, L.P. | 11,296 | $12.3K | 0.00% | −3,687−24.6% | Reduced |
| JPMorgan Chase & Co | 11,449 | $12.5K | 0.00% | −13,142−53.4% | Reduced |
| Independent Advisor Alliance | 12,500 | $13.6K | 0.00% | −14−0.1% | Reduced |
| Citadel Advisors LLC | 14,120 | $15.4K | 0.00% | −93,768−86.9% | Reduced |
| Ameriprise Financial Inc | 18,007 | $19.6K | 0.00% | −4,800−21.0% | Reduced |
| Citigroup Inc | 19,310 | $21.0K | 0.00% | −495,601−96.2% | Reduced |
| Squarepoint Ops LLC | 21,896 | $23.9K | 0.00% | −51,119−70.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 22,900 | $25.0K | 0.00% | −12,300−34.9% | Reduced |
| Morgan Stanley | 28,066 | $30.6K | 0.00% | −13,697−32.8% | Reduced |
| HSBC Holdings PLC | 30,891 | $32.7K | 0.00% | −8,189−21.0% | Reduced |
| Barclays PLC | 30,197 | $32.9K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 33,600 | $37.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 34,706 | $37.8K | 0.00% | −9,862−22.1% | Reduced |
| Velan Capital Investment Management LP | 35,000 | $38.1K | 0.04% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 62,134 | $67.7K | 0.00% | −6,979−10.1% | Reduced |
| Panagora Asset Management Inc | 89,631 | $97.7K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 90,263 | $98.4K | 0.00% | −30,982−25.6% | Reduced |
| ADAR1 Capital Management, LLC | 101,008 | $110.1K | 0.02% | 00.0% | Unchanged |
| Walleye Capital LLC | 101,696 | $110.8K | 0.00% | −25,930−20.3% | Reduced |
| Northern Trust Corp | 107,346 | $117.0K | 0.00% | +60.0% | Added |
| Assenagon Asset Management S.A. | 115,038 | $125.4K | 0.00% | −38,663−25.2% | Reduced |
| Dimensional Fund Advisors LP | 126,004 | $137.4K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 129,914 | $141.6K | 0.00% | −409,979−75.9% | Reduced |
| Evoke Wealth, LLC | 133,122 | $145.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 148,800 | $162.2K | 0.00% | −53,300−26.4% | Reduced |
| UBS Group AG | 152,283 | $166.0K | 0.00% | −123,181−44.7% | Reduced |
| Millennium Management LLC | 155,389 | $169.4K | 0.00% | −162,631−51.1% | Reduced |
| State Street Corp | 157,578 | $171.8K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 245,561 | $267.7K | 0.02% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 267,636 | $291.7K | 0.00% | −103,284−27.8% | Reduced |
| Two Sigma Investments, LP | 353,227 | $385.0K | 0.00% | −153,759−30.3% | Reduced |
| Geode Capital Management, LLC | 430,792 | $469.7K | 0.00% | +9,082+2.2% | Added |
| Peapod Lane Capital LLC | 489,370 | $533.4K | 0.60% | +43,626+9.8% | Added |
| Two Sigma Advisers, LP | 505,600 | $551.1K | 0.00% | −209,000−29.2% | Reduced |
| Aldebaran Capital, LLC | 523,553 | $570.7K | 0.54% | +21,363+4.3% | Added |
| Stonepine Capital Management, LLC | 630,183 | $686.9K | 0.80% | +94,378+17.6% | Added |
| D. E. Shaw & Co., Inc. | 949,726 | $1.04M | 0.00% | −74,562−7.3% | Reduced |
| BlackRock, Inc. | 1,144,396 | $1.25M | 0.00% | −2,088−0.2% | Reduced |
| Acadian Asset Management LLC | 2,047,177 | $2.23M | 0.01% | −31,689−1.5% | Reduced |
| Vanguard Group Inc | 2,175,061 | $2.37M | 0.00% | +31,959+1.5% | Added |
| Alkeon Capital Management LLC | 2,342,373 | $2.55M | 0.02% | −1,358−0.1% | Reduced |
| Euclidean Capital LLC | 2,627,643 | $2.86M | 1.08% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 3,301,942 | $3.60M | 0.28% | +1,222,697+58.8% | Added |
| ArrowMark Colorado Holdings LLC | 3,308,677 | $3.61M | 0.06% | −199,774−5.7% | Reduced |
| Sio Capital Management, LLC | 3,735,396 | $4.07M | 1.23% | +163,229+4.6% | Added |
| BML Capital Management, LLC | 3,747,612 | $4.08M | 3.31% | +280,928+8.1% | Added |
| OrbiMed Advisors LLC | 6,475,291 | $7.06M | 0.17% | 00.0% | Unchanged |
| M&T Bank Corp | 0 | $0 | 0.00% | −399,548−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −322,024−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −156,451−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −64,009−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −49,870−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −32,603−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −28,700−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −24,880−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16,935−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,014−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,877−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,034−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,595−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,320−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −105−100.0% | Sold out |